Caravel Expands into Iowa and Missouri Amid ABA Service Shortages

Back-to-Back Openings Target Access Barriers

LIBERTY, MISSOURI — Caravel Autism Health completed back-to-back ribbon cuttings in Des Moines, Iowa on April 14 and in Liberty, Missouri on April 16, bringing the private-equity-backed provider into two new Midwestern markets that have been chronically underserved by specialized autism therapy providers. The dual openings represent separate market entries, Des Moines and the Kansas City metropolitan area, each targeting communities where families have faced months-long wait times for ABA therapy intake and evaluation.

The Des Moines clinic at 475 Southwest 5th Street, Suite 200 represents the company’s first Iowa location, while the Liberty center at 560 Rush Creek Parkway joins a previously opened Shawnee clinic as part of a deliberate Kansas City metro buildout. Sara Scheible, M.S., BCBA, LBA, Clinic Director for the Liberty location, emphasized the urgency of eliminating access barriers for families in the Northland community.

The expansion follows GTCR’s acquisition of Caravel from Frazier Healthcare Partners, which closed in mid-2024. GTCR, a Chicago-based private equity firm founded in 1980 that has invested more than $30 billion in over 280 companies and manages approximately $45 billion in equity capital, brings significant resources and operational expertise to Caravel’s expansion strategy. Harris Williams advised Caravel on the sale to GTCR, while TripleTree served as exclusive financial advisor to GTCR for the transaction.

“At Caravel, our mission is to change lives. We do this by bringing our specialized teams into communities where families have lacked access to high-quality care.” — Mike Miller, CEO, Caravel Autism Health

Market Response to Autism Service Shortage

Both new markets present compelling dynamics for ABA providers willing to invest in infrastructure and staffing. According to the CDC’s most recent ADDM Network surveillance data, released in April 2025, autism prevalence has risen to approximately 1 in 31 children aged 8 years. That figure, which reflects data collected in 2022 across 16 monitoring sites in 14 states, represents a continued upward trend from the previous estimate of 1 in 36, driving sustained demand growth for behavioral health services across the country.

The Kansas City market in particular features a fragmented competitive landscape dominated by smaller, regional players including Summit Behavioral Services, Heartland Behavioral Health, and a network of independent BCBAs operating in-home practices. National players with Kansas City metro presence remain limited, creating an opening for a well-capitalized platform like Caravel to establish market presence with a differentiated service model that emphasizes immediate enrollment availability.

Caravel’s approach differs from purely home-based models by offering center-based services with sensory-friendly environments designed specifically for young children. The centers feature specialized therapy spaces, structured programming, and one-on-one treatment sessions with certified behavior analysts. This center-based model provides a controlled clinical environment that many families prefer and that supports more intensive treatment protocols.

Caravel reports immediate availability for new enrollments at both locations, contrasting with industry-standard wait times that can extend months in underserved markets. This no-waitlist positioning is a central element of the company’s market entry strategy, addressing one of the most significant pain points families experience when seeking ABA services. Local news coverage from KSHB 41 in Kansas City highlighted the impact of this approach, profiling a mother whose three-year-old daughter was able to bypass the typical waitlist because her diagnosis coincided with the Liberty clinic’s opening.

Private Equity Fuels Geographic Expansion

The dual-market approach reflects broader strategic themes in ABA industry consolidation, where well-capitalized platforms prioritize selective geographic expansion in underserved markets with favorable demographics and reimbursement environments. GTCR’s Leaders Strategy, the firm’s signature approach of partnering with management leaders in core domains to build market-leading companies through organic growth and strategic acquisitions, aligns with Caravel’s existing leadership team and growth trajectory.

Mike Miller, CEO of Caravel Autism Health, brings prior leadership experience at Wolf Point Growth Partners, LLC, where he served as Managing Partner, and at CIVC Partners. Miller joined Caravel in 2014 and holds an MBA from the Kellogg School of Management at Northwestern University. Under his leadership, Caravel has expanded from a Wisconsin-focused provider to a nine-state platform serving families across the Midwest and Pacific Northwest.

The GTCR acquisition enables Caravel to accelerate its clinic development pipeline, invest in technology infrastructure including its proprietary PathTap outcomes platform, and recruit the clinical talent necessary to staff new locations. PathTap, trademarked in November 2021, provides data-driven outcomes tracking that the company says has contributed to more than a 40 percent improvement on targeted clinical quality components since its implementation in 2022. For PE sponsors evaluating ABA investments, outcomes measurement platforms like PathTap provide the kind of quantifiable clinical metrics that support both clinical quality narratives and reimbursement negotiations.

GTCR’s healthcare investment portfolio extends across multiple sub-sectors, giving the firm cross-industry operational insight that complements Caravel’s clinical expertise. The firm’s collaborative, value-add approach to building portfolio companies, combined with its deep sector expertise in healthcare services, positions Caravel to execute expansion at an accelerated pace while maintaining the clinical quality standards that differentiate the company from newer market entrants.

Competitive Positioning and Clinical Differentiation

Caravel’s market entry strategy emphasizes clinical quality credentials alongside access promises. The company’s internal Clinical Center of Excellence, an advisory body composed of its most experienced clinicians, designs best practices and sets performance measurements that guide clinical teams across all locations. Caravel also maintains accreditation from the Behavioral Health Center of Excellence, a third-party quality validation organization whose accreditation is shared with other PE-backed platforms including Behavior Frontiers and Lighthouse Autism Center.

The Liberty location is directed by Sara Scheible, M.S., BCBA, LBA, while the Des Moines facility operates under Alexis Alvarez, M.A., BCBA, LBA. Both directors hold advanced credentials and state licensure, reflecting Caravel’s investment in experienced clinical leadership at the local level. This credentialed leadership model contrasts with some PE-backed expansion strategies that have drawn criticism for prioritizing speed over clinical depth.

“Families shouldn’t have to wait months or years to get answers and support. By adding new clinics, we’re eliminating the backlog and removing barriers to accessing care.” — Sara Scheible, M.S., BCBA, LBA, Clinic Director, Caravel Autism Health, Liberty

The clinical approach utilizes Applied Behavior Analysis principles recognized by the American Academy of Pediatrics and the Centers for Disease Control and Prevention as evidence-based treatment for autism spectrum disorder. Caravel serves children between the ages of 12 months and 11 years, with a focus on early intervention during the developmental years when ABA therapy has demonstrated the greatest impact on skill acquisition, communication development, and school readiness.

Forward Expansion Plans and Insurance Coverage

Caravel announced plans to open additional locations in Olathe, Kansas and Kansas City South during summer 2026. Those openings would bring the company’s Kansas City metro presence to four clinics, establishing meaningful geographic density within a single market. This density-first approach mirrors the expansion strategies of other successful ABA platforms that have demonstrated strong unit economics through concentrated regional presence.

Founded in 2009, Caravel now operates centers across nine states: Idaho, Illinois, Indiana, Iowa, Kansas, Minnesota, Missouri, Washington, and Wisconsin. The multi-state footprint provides geographic diversification that reduces exposure to any single state’s reimbursement environment or regulatory framework. Each state has distinct Medicaid policies, autism insurance mandates, and regulatory structures that create different operating dynamics for ABA providers. Iowa’s relatively concentrated market and Kansas’s evolving KanCare Medicaid landscape present different challenges and opportunities than Wisconsin’s mature ABA market where Caravel has its deepest roots.

Both new locations accept most major insurance providers. Per Caravel’s center pages, in-network plans include Aetna, Anthem BCBS, and Cigna among more than 65 additional plans at various locations. This extensive insurance acceptance addresses a key barrier families face when seeking ABA services, as coverage requirements and authorization processes vary significantly across payers and often create administrative obstacles to accessing care.

For Kansas families specifically, the company works with Kansas state private insurance coverage requirements and KanCare Medicaid programs. The Kansas insurance landscape for ABA therapy has been shaped by the state’s autism insurance mandate, which requires coverage for ABA services but allows variation in age limits, benefit caps, and authorization requirements across plans. Caravel’s ability to navigate these payer-specific requirements across multiple states reflects the administrative infrastructure that PE capital enables.

Operational Maturity and the GTCR Growth Thesis

The combination of immediate availability, comprehensive insurance acceptance, and clinical quality positioning creates what Caravel leadership describes as a differentiated model designed to eliminate the barriers that have historically prevented families from accessing ABA services in a timely manner. Whether this model translates into sustainable growth and clinical outcomes in the competitive Midwestern ABA market will determine the trajectory of GTCR’s investment thesis.

The dual-market opening strategy, Des Moines on Monday and Liberty on Wednesday, reflects an operational confidence that comes from Caravel’s 17-year history of clinic development. Founded in 2009, the company has refined its market entry playbook through multiple state expansions, developing institutional knowledge about the regulatory, staffing, and community engagement requirements that determine whether a new clinic achieves sustainable enrollment within its first year. This operational maturity distinguishes Caravel from newer entrants to the ABA market that may lack the institutional experience to execute simultaneous multi-market launches efficiently. The GTCR acquisition amplifies this existing capability with the capital resources to execute at an accelerated pace.

The PathTap outcomes platform represents a significant operational asset for Caravel’s expansion strategy. In an industry where clinical outcome measurement has historically been inconsistent across providers, a proprietary outcomes tracking system provides both clinical quality infrastructure and a data asset that supports multiple strategic objectives. For clinical operations, PathTap enables standardized outcome measurement across all locations, ensuring that the quality of care in a newly opened Liberty clinic can be compared directly to established Wisconsin locations. For payer relationships, outcomes data provides quantitative evidence that supports reimbursement negotiations and utilization review responses.

The clinical leadership model Caravel employs at new locations, credentialed BCBA clinic directors with advanced degrees and state licensure, reflects an investment in local clinical expertise that distinguishes Caravel from some PE-backed expansion models that have drawn criticism for thin clinical supervision. Sara Scheible’s credentials in Liberty and Alexis Alvarez’s credentials in Des Moines demonstrate a commitment to placing experienced clinical leadership at the front lines of new market entry, providing families with confidence that the provider backing a national brand is also investing in local clinical depth.

The competitive landscape in the Kansas City metro area is expected to intensify as Caravel adds its planned Olathe and Kansas City South locations during summer 2026. Four clinics within a single metropolitan area would create the kind of geographic density that supports brand recognition, referral network development, and operational efficiency. This density-first approach has been validated by other successful ABA platforms and suggests that Caravel’s Kansas City strategy is designed for sustained market presence rather than opportunistic market testing.

For Iowa families, the Des Moines opening represents a significant expansion of accessible ABA options in a market that has been constrained by limited provider capacity. Iowa’s autism insurance mandate and Medicaid coverage framework provide the reimbursement foundation for center-based ABA services, but provider supply has not kept pace with the growing demand driven by rising autism prevalence and increased awareness of early intervention benefits. Caravel’s entry into Des Moines, backed by GTCR’s resources and operational support, positions the company to address this supply gap with a model that has been refined across eight other states over the past 17 years.

GTCR’s track record in healthcare growth equity provides Caravel with more than capital. The firm brings operational expertise, industry relationships, and strategic guidance that complement the management team’s clinical and operational knowledge. With more than $45 billion in equity capital under management and a portfolio spanning financial services, healthcare, technology, and business services, GTCR has the resources and cross-sector insight to support Caravel’s growth trajectory through multiple expansion phases, including clinic development, technology investments, and potential add-on acquisitions that could accelerate the company’s geographic reach.

The more than 40 percent improvement in targeted clinical quality components that Caravel attributes to PathTap implementation provides a compelling clinical narrative for payer negotiations, though the specific methodology and comparison basis for this figure warrant independent examination. Nonetheless, the willingness to publish outcome metrics signals a provider that is investing in the kind of clinical accountability infrastructure that payers and PE sponsors increasingly expect. For GTCR, this outcomes infrastructure likely represented a significant element of the investment thesis, a clinical quality foundation that supports both growth and defensibility in an industry where reimbursement depends on demonstrable value.

In May 2025, Caravel further strengthened its clinical leadership by appointing Dr. Adam Hahs, PhD, BCBA-D, LBA, as Chief Clinical Officer. Dr. Hahs, who previously served as chief science officer for Hopebridge Autism Therapy Centers and as director of the MSABA program at Arizona State University, brings a research-oriented perspective to Caravel’s clinical strategy. His appointment signals Caravel’s intent to position itself at the intersection of clinical practice and outcomes research, an increasingly important differentiator as payers demand evidence-based justification for ABA service authorization and continued treatment.

The broader ABA industry context makes Caravel’s expansion timing notable. The secondary buyout market for ABA platforms reactivated in 2024 after a period of stagnation, with Caravel’s sale to GTCR representing one of the year’s most significant transactions alongside Tenex Capital Management’s acquisition of Behavioral Innovations from Shore Capital Partners. These transactions signaled renewed investor confidence in the ABA sector’s long-term fundamentals, even as providers continue to navigate challenges including reimbursement pressures, workforce shortages, and rising operational costs.

AT A GLANCE

SOURCES & REFERENCES